Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glucolipid metabolism pathway" refers to the integrated biochemical network responsible for the regulated processing of both glucose and lipids within cells and across organ systems. This network is fundamental for cellular energy production, storage, and utilization and involves enzymes, transporters, receptors, and signaling molecules that maintain homeostasis of blood sugar and fat levels. Dysregulation of these pathways is central to the pathogenesis of metabolic diseases such as diabetes, obesity, nonalcoholic fatty liver disease (NAFLD), and cardiovascular diseases[4][5][6]. Rather than a specific protein or drug target, "glucolipid metabolism pathway" encompasses numerous proteins, such as acetyl-CoA carboxylase (ACC), fatty acid synthase (FASN), glucose transporter type 2 (GLUT2), and transcription factors like ATF3, which collectively regulate these metabolic processes[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucolipid metabolism pathway.